Natus completes acquisition of Nicolet neurodiagnostic business

Tuesday, July 3, 2012 10:32 AM

Natus Medical, a San Carlos, Calif.-based provider of healthcare products, has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion for an approximate $58 million cash.

 “The Nicolet acquisition strengthens our leadership position in neurodiagnostic and monitoring products,” said Jim Hawkins, CEO of Natus. “The Nicolet portfolio of electroencephalography (EEG) and electromyography (EMG) systems and related accessories, as well as vascular and obstetric Doppler sensors and connectivity products, will allow us to bring additional value to our customers as well as adding to our customer base around the world.”

Based in Middleton, Wis., the Nicolet neurodiagnostic business employs more than 400 people worldwide and generated sales of approximately $95 million in 2011.

“We expect this acquisition to be marginally accretive to non-GAAP earnings in the fourth quarter of this year and to significantly improve our profitability in 2013,” said Hawkins. “Integration activities should be substantially completed by the end of 2012.”

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs